Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk: The Debate Is Over

JAMA Cardiol. 2022 Mar 1;7(3):257-258. doi: 10.1001/jamacardio.2021.5080.

Authors

Allan D Sniderman¹, Ann Marie Navar^{1

2}, George Thanassoulis¹

Affiliations

¹ Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
² Associate Editor, JAMA Cardiology.

PMID: 34773457
DOI: 10.1001/jamacardio.2021.5080

No abstract available

Publication types

Comment

MeSH terms

Apolipoproteins B
Atherosclerosis*
Cholesterol
Cholesterol, LDL
Humans
Lipoproteins
Myocardial Infarction*

Substances

Apolipoproteins B
Cholesterol, LDL
Lipoproteins
Cholesterol